Skip to content

Randomized controlled trial for intermittent fasting therapy for nonalcoholic fatty liver disease

Randomized controlled trial for intermittent fasting therapy for nonalcoholic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020871
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

1:Health education, sports guidance,Intermittent fasting for 1 day per week
2:Health education, sports guidance,Intermittent fasting for 2 days per week
3:Health education, sports guidance

Sponsors

Nanchang Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with nonalcoholic fatty liver disease; (2) Age 18-70 years old; (3) Light physical laborers; (4) Subjects are required to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Other liver diseases and drug-induced liver damage; (2) Diabetic patients (FPG=7.0mmol/L and/or OGTT 2h PG=11.1mmol/L); (3) Hypertensive patients (systolic blood pressure =140 mmHg and / or diastolic blood pressure =90 mmHg or taking antihypertensive drugs); (4) Those who participated in the study three months before, or participated in other research trials at the same time; (5) Those who were enrolled in the study three months ago, or at the same time; (6) obvious renal insufficiency (creatinine = 1.5 mg / dl or > 133umol / L); (7) Those who have had a history of stroke or myocardial infarction; (8) have done or are preparing for coronary balloon dilatation or coronary artery bypass surgery; (9) suffering from other serious diseases such as malignant tumors; (10) pregnant or lactating women; (11) The subject considered by the investigator not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;Waist circumference;Hip circumference;Waist-to-hip ratio;Liver function;

Countries

China

Contacts

Public ContactFan Yibing

Nanchang Center for Disease Control and Prevention

fan_yibing@163.com+86 18079167858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026